IceCure Medical Ltd. Shareholders Approve All Agenda Items at Annual Meeting
Ticker: ICCM · Form: 6-K · Filed: Aug 20, 2025 · CIK: 1584371
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
IceCure Medical Ltd. shareholders gave a green light to everything on the agenda at their August 20th meeting.
AI Summary
On August 20, 2025, IceCure Medical Ltd. held its Annual and Special General Meeting of Shareholders. A quorum was present, and shareholders approved all agenda items presented at the meeting, as previously detailed by the company.
Why It Matters
The approval of all agenda items by shareholders signifies that the company's proposed actions and resolutions have received the necessary backing, allowing management to proceed with their plans.
Risk Assessment
Risk Level: low — This filing is a routine report of a shareholder meeting where all proposed items were approved, indicating no new or unexpected risks.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- August 20, 2025 (date) — Date of Annual and Special General Meeting of Shareholders
FAQ
What type of meeting did IceCure Medical Ltd. hold on August 20, 2025?
IceCure Medical Ltd. convened its Annual and Special General Meeting of Shareholders on August 20, 2025.
Was a quorum present at the meeting?
Yes, a quorum was present at the Annual and Special General Meeting of Shareholders.
What was the outcome of the shareholder vote?
Shareholders voted upon and approved, by the applicable required majority, all agenda items that were described in the Company's previous filings.
What form does IceCure Medical Ltd. file its annual reports under?
IceCure Medical Ltd. files its annual reports under Form 20-F.
Where is IceCure Medical Ltd. located?
IceCure Medical Ltd. is located at 7 Ha'Eshel St., PO Box 3163, Caesarea, 3079504, Israel.
Filing Stats: 309 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2025-08-20 17:09:05
Filing Documents
- ea0254086-6k_icecure.htm (6-K) — 11KB
- 0001213900-25-079033.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IceCure Medical Ltd. Date: August 20, 2025 By: /s/ Eyal Shamir Name: Eyal Shamir Title: Chief Executive Officer 2